Island Pharmaceuticals (ASX:ILA) Pre-Tax Income : A$-3.24 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Island Pharmaceuticals Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Island Pharmaceuticals's pretax income for the six months ended in Dec. 2024 was A$-1.53 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was A$-3.24 Mil. Island Pharmaceuticals's pretax margin was %.

During the past 4 years, Island Pharmaceuticals's highest Pretax Margin was -228.75%. The lowest was -25727.27%. And the median was -12978.01%.

Island Pharmaceuticals Pre-Tax Income Historical Data

The historical data trend for Island Pharmaceuticals's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Island Pharmaceuticals Pre-Tax Income Chart

Island Pharmaceuticals Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Pre-Tax Income

-2.13

-2.61

-2.83

-2.86

Island Pharmaceuticals Semi-Annual Data
	Jun20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Pre-Tax Income	Get a 7-Day Free Trial				-1.61	-1.22	-1.16	-1.71	-1.53

Competitive Comparison of Island Pharmaceuticals's Pre-Tax Income

For the Biotechnology subindustry, Island Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Island Pharmaceuticals's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Island Pharmaceuticals's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Island Pharmaceuticals's Pre-Tax Income falls into.

Save Embed

;

Save Embed

;

Island Pharmaceuticals Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Island Pharmaceuticals's Pretax Income for the fiscal year that ended in Jun. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-2.874	+	0.051	+	-0.046	+	0.005	+	0
	=	-2.86

Island Pharmaceuticals's Pretax Income for the quarter that ended in Dec. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-1.604	+	0.098	+	-0.027	+	0	+	0
	=	-1.53

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-3.24 Mil.

Island Pharmaceuticals (ASX:ILA) Pre-Tax Income Explanation

Island Pharmaceuticals's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-1.533	/	0
	=	%

During the past 4 years, Island Pharmaceuticals's highest Pretax Margin was -228.75%. The lowest was -25727.27%. And the median was -12978.01%.

Island Pharmaceuticals Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Island Pharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Island Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Island Pharmaceuticals Ltd (ASX:ILA) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/- Bio101 Financial Advisory Pty Ltd, 697 Burke Road, Suite 201, Camberwell, Melbourne, VIC, AUS, 3124

Website

https://www.islandpharmaceuticals.com

Island Pharmaceuticals Ltd is a drug research and repurposing company focused on developing preventative or therapeutic drugs for viral infections. Its drug candidate ISLA-101 is a drug with a well-established safety profile, being repurposed for the prevention and treatment of dengue fever and another mosquito (or vector) borne diseases. The company carries out its research and development activities principally in the geographic regions of Australia and the United States of America.

Island Pharmaceuticals Headlines

No Headlines